Hungary Dr Ildikó Horvath, Hungary’s State Secretary for Health explains her role and shares insights on the key health trends in Hungary, the government’s top priority in improving healthcare, the importance of digitalization, and efforts made to close the life expectancy gap with Europe. Hungary is on average five years…
Hungary Dr. György Blaskó, former President and Chairman of the Hungarian European Clinical Research Infrastructure Network, explains the role of the research network, the impact it has on the Hungarian clinical research environment, and the areas of improvement moving forward. Domestic centralized health care and the presence of a single…
Puerto Rico Exel F. Colon, President of ECR Engineering, a Puerto Rican company specialized in water and wastewater treatment with expertise in the life sciences industry, explains what makes water critical for life sciences manufacturers, how his company helps them reduce water consumption, reduce costs and comply with regulations. He also shares…
Korea Syneos Health, established through a merger in 2017, has held a foothold in Korea through its legacy organisations for over 10 years. Sora Lee, general manager of Syneos Korea, provides her assessment of the impact of the merger. She also comments on Syneos Health’s MoU with KoNECT (Korea National Enterprise…
Baltics As the Lithuanian market matures, profound shifts have been taking place in the arena of human resources and how drug developers go about identifying, acquiring and retaining the personnel they require for a new age of medical science. “There are a number of emerging trends underway that are forcing companies…
USA Rolando Pablos, Secretary of State of Texas, discusses Texas’s unique business-friendly environment, the significance of the life sciences sector to the state’s economy (which would be the tenth largest in the world were Texas a country), innovation, and internationalization. Across the board we are industry agnostic, meaning that whatever…
Philippines Enrique Ona, the former Secretary of Health in the Philippines, discusses his tenure as secretary of state, the effects of revenues from a “sin tax” on expanding universal healthcare to all Filipino citizens, as well as some of the challenges being faced in fully realizing this goal. He also discusses…
Pharma FDI into Irish pharma has almost exclusively targeted in biologics production over the last few years, largely due to Ireland’s skilled workforce of bioprocessing technicians. NIBRT director Dominic Carolan discusses how the institute supports the Irish biopharma industry through training and recruitment solutions, while pursuing research that may help to…
Pharma The Center for Pharmaceutical Engineering and Learning (CPEDaL) was established in 2006 as a ten year training program that is currently awaiting funding for the next five years. Carlos Velázquez, director of CPEDaL, explains how the Center introduces high school students to pharmaceutical engineering and their pioneering work in mixing…
BeCRO What was the motivation behind the establishment of BeCRO and why was it only established in 2010 given the strength of Belgium’s clinical trials industry? Philippe van der Hofstadt: Prior to establishing BeCRO, several of our members were already participants of other associations that also included pharmaceutical companies and academia,…
ireland Mr. Mazeman, can you please begin by offering a brief overview of your career to date? I am a French pharmacist by training, with expertise in pharmacology. I have worked for Servier for my entire career. I started in the industry as a medical representative for the company. I went…
See our Cookie Privacy Policy Here